Yuri Maricich

CIK 1881045 · Chief Medical Officer · last filed 2026-08-05

Yuri Maricich is a Chief Medical Officer who has filed 10 SEC Form 4 insider transactions across 2 companies since 2021. The most recent filing shows the insider bought $10.8K of CAMP on Aug 5, 2026. Across all open-market trades the lifetime net is +$7.1K, making them a net buyer over the disclosed history. Current disclosed insider exposure totals $58.6K across reported positions.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$58.6K

Companies

2

Total Filings

10

Lifetime Open-Market Net

$7.1K

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
CAMP Chief Medical Officer 12,611 $4.65 $58.6K $20.8K 5 2026-08-05
Pear Therapeutics, Inc. (PEARW) Delisted Chief Medical Officer 94,333 $0.01 $557 -$13.7K 5 2023-02-17

Recent Filings

10 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2026-08-05 CAMP Buy (P) +6,551 $10.8K EDGAR
2026-04-03 CAMP Grant (A) $0 EDGAR
2025-12-22 CAMP Grant (A) $0 EDGAR
2025-09-11 CAMP Buy (P) +6,060 $10.0K EDGAR
2025-04-03 CAMP Grant (A) $0 EDGAR
2023-02-17 Pear Therapeutics, Inc. (PEARW) Delisted Grant (A) $0 EDGAR
2023-01-24 Pear Therapeutics, Inc. (PEARW) Delisted Sell (S) −12,162 -$13.7K EDGAR
2023-01-18 Pear Therapeutics, Inc. (PEARW) Delisted Exer (M) +30,800 $0 EDGAR
2022-02-18 Pear Therapeutics, Inc. (PEARW) Delisted Grant (A) $0 EDGAR
2021-12-07 Pear Therapeutics, Inc. (PEARW) Delisted Grant (A) +73,620 $0 EDGAR
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.